^

Health

Setegis

, medical expert
Last reviewed: 23.04.2024
Fact-checked
х

All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.

We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.

If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.

Setegis has an α-adrenolytic effect.

The drug helps to block the activity of α1-adrenergic receptors located inside the smooth muscles of the prostate, a certain part of the urethra, and besides this, the neck of the urea; as a result, there is a decrease in resistance to urinary current and an improvement in overall urodynamics in people who suffer from prostate adenoma. At the same time, the drug does not affect the size of the prostate.

trusted-source[1]

Indications Setegis

It is used in such situations:

  • combination therapy for prostate adenoma ;
  • reduction of increased blood pressure (in combination with other medicines or as a monotherapeutic agent).

Release form

The release of the therapeutic component is implemented in tablets with a volume of 1, as well as 2, or 5 mg. Inside the cell plate contains 10 tablets; in the box - 3 such records.

Pharmacodynamics

The basis of the hypotensive effect of drugs is the expansion of arterioles with venules. The drug weakens the post- and preload in relation to the heart muscle, reduces the values of blood pressure and CRPS, and in addition reduces the return of venous blood to the heart.

The maximum therapeutic effect of drugs is observed after 2-3 hours after oral administration and lasts for 24 hours. The drug has almost no effect on the rate of CF, renal perfusion, and cardiac output. With prolonged use of the substance does not develop reflex tachycardia nature. When used in medical portions, terazosin reduces the overall level of blood cholesterol by 2-5%.

Pharmacokinetics

The drug at high speed and almost completely absorbed inside the gastrointestinal tract; however, the absorption does not depend on the consumption of food.

The bioavailability of terazosin is about 90%. 95% of the drug is synthesized with blood protein. Oral Cmax blood counts are noted after the 1st hour.

Excretion is done through the kidneys with intestines.

Dosing and administration

The tablet must be swallowed whole, without chewing. In the case of therapy with increased values of blood pressure, a portion of drugs is selected individually, taking into account the level of blood pressure.

The size of the initial dosage is 1 mg; It is necessary to use medicine in the evening, before a dream. Because there is a possibility of a strong decrease in blood pressure after taking the first portion, the initial dosage is forbidden to exceed. Later, the daily portion is gradually increased until a normal blood pressure index is reached. Approximately the portion is doubled with 5-7 days intervals.

The size of the maintenance dosage in the case of increased values of blood pressure is 2-10 mg per day (one-time dose). A subsequent increase in daily rations does not increase drug efficacy.

In the case of prostate adenoma, it is necessary to use 1 to 5 times a day for 5-10 mg of the drug. Since dosages higher than 10 mg per day do not bring the desired result, they are not used.

trusted-source[5]

Use Setegis during pregnancy

The drug can not be used in pregnant or nursing.

Contraindications

The main contraindications:

  • severe intolerance associated with the drug or other α-adrenoreceptor antagonist substances;
  • decreased blood pressure values.

Caution is needed in case of appointment in such situations:

  • blood flow disorders within the brain;
  • angina or coronary artery disease;
  • failure of renal or hepatic work;
  • type 1 diabetes.

Side effects Setegis

Among the adverse events:

  • thrombocytopenia;
  • intense heartbeat, orthostatic collapse, vasodilation, tachycardia and a decrease in blood pressure;
  • dizziness, fainting, drowsiness, paresthesias, and headaches;
  • runny nose, sinusitis, dyspnea, and nasal congestion;
  • dryness of the oral mucous membranes, vomiting, diarrhea, constipation, nausea, and also bloating, pain affecting the abdominal area, and dyspepsia;
  • itching or rashes, and hyperhidrosis;
  • pains developing in the back or limbs.

trusted-source[2], [3], [4]

Overdose

In case of poisoning, there is a decrease in blood pressure, coordination disorder and syncope.

Interactions with other drugs

Caution should be combined with other drugs with hypotensive properties. Sometimes in such cases it is required to adjust the portion of Setegis.

Antacid sorbents reduce the absorption of the drug.

The effect of the drug is reduced in the case of a combination with NSAIDs and adrenergic stimulants.

trusted-source[6]

Storage conditions

Setegis is required to be kept at temperature values not exceeding 30 ° C.

trusted-source

Shelf life

Setegis can be used for a 36-month period from the moment the drug is manufactured.

trusted-source

Application for children

There is no information regarding efficacy and drug safety, which is why Setegis is forbidden to use in pediatrics.

trusted-source

Analogs

Analogues of the medication are the substances Khaitrin and Kornam with Terazosin.

trusted-source[7]

Reviews

Setegis is often discussed regarding the treatment of prostate adenoma. There are a variety of reviews - the drug has helped someone, but there are also those who consider it completely useless.

Doctors write that using drugs for 4 months leads to an increase in the speed and volume of urination, as well as a decrease in the time of the urinary process and the volume of the so-called residual urine.

The drug is tolerated without complications and is considered fairly safe (only 3% of those treated had to stop its use). The appearance of negative symptoms is observed only in 8.3% of patients.

Attention!

To simplify the perception of information, this instruction for use of the drug "Setegis" translated and presented in a special form on the basis of the official instructions for medical use of the drug. Before use read the annotation that came directly to medicines.

Description provided for informational purposes and is not a guide to self-healing. The need for this drug, the purpose of the treatment regimen, methods and dose of the drug is determined solely by the attending physician. Self-medication is dangerous for your health.

Translation Disclaimer: For the convenience of users of the iLive portal this article has been translated into the current language, but has not yet been verified by a native speaker who has the necessary qualifications for this. In this regard, we warn you that the translation of this article may be incorrect, may contain lexical, syntactic and grammatical errors.

You are reporting a typo in the following text:
Simply click the "Send typo report" button to complete the report. You can also include a comment.